BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8595535)

  • 1. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
    Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
    Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
    JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
    Berger A; Doerr HW; Scharrer I; Weber B
    J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
    Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
    Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
    Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
    Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score.
    Caldwell SH; Li X; Rourk RM; Millar A; Sosnowski KM; Sue M; Barritt AS; McCallum RW; Schiff ER
    Am J Gastroenterol; 1993 Jul; 88(7):1016-21. PubMed ID: 8391209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
    J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.
    Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
    Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency.
    Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J
    Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.